CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

1148 results.
Study Number Lead Group Study Title CIRB Study Status
9837 ETCTN Phase I Study of TRC102 in Combination with Cisplatin and Pemetrexed in Patients with Advanced Solid Tumors / Phase II Study of TRC102 with Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin Adult CIRB - Early Phase Emphasis Available to Open
URCC-19085 NCORP-University of Rochester Cancer Center Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial Cancer Prevention and Control CIRB Available to Open
10553 ETCTN A Phase 2 Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naïve Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer Adult CIRB - Early Phase Emphasis Available to Open
NRG-BR009 NRG A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score ≤ 25 (OFSET) Adult CIRB - Late Phase Emphasis Available to Open
EA8153 ECOG-ACRIN Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel: the CHAARTED2 Trial Adult CIRB - Late Phase Emphasis Available to Open
ACCL1033 COG A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL: A Group-wide Non-Therapeutic Study Pediatric CIRB Available to Open
WF-1805CD NCORP-Wake Forest University Implementation and Effectiveness Trial of HN-STAR Cancer Prevention and Control CIRB Available to Open
A031901 Alliance Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial Adult CIRB - Late Phase Emphasis Available to Open
1148 results.